Lifecore Biomedical to Present at Stephens Annual Investment Conference
Lifecore Biomedical (NASDAQ: LFCR) has announced its participation in the upcoming Stephens Annual Investment Conference, scheduled for November 19-21, 2024, in Nashville, Tennessee.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lifecore Biomedical (NASDAQ: LFCR) has announced its participation in the upcoming Stephens Annual Investment Conference, scheduled for November 19-21, 2024, in Nashville, Tennessee. The company's president and CEO, Paul Josephs, will be featured in a fireside chat on Tuesday, November 19, 2024, at 2:00 p.m. Central time at the Grand Hyatt Nashville. Additionally, Lifecore management will be available for one-on-one meetings during the conference.
Details
News Market Reaction – LFCR
The recorded move for LFCR in the trading session of this news was +1.00%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs, the company’s president and chief executive officer, will be a featured speaker in a fireside chat at the upcoming Stephens Annual Investment Conference. The conference is being held November 19-21, 2024, in Nashville, Tennessee.
Details regarding Lifecore’s participation are as follows:
- Stephens Annual Investment Conference
Details: Mr. Josephs will be a featured speaker in a fireside chat and Lifecore management will participate in 1-on-1 meetings
Conference Dates: November 19-21, 2024
Fireside Chat Timing: 2:00 p.m. Central on Tuesday, November 19, 2024
Location: Grand Hyatt Nashville
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.